Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

Novavax announces vaccine’s high efficacy against original and variant COVID-19 strains

March 12, 2021 Medical Communications COVID-19, Novavax, vaccines

Novavax has announced final efficacy of 96.4% against mild, moderate, and severe disease caused by the original COVID-19 strain in …
News
lonza

Altimmune expands COVID-19 vaccine manufacturing deal with Lonza

March 12, 2021 Medical Communications Altimmune, COVID-19, Lonza, vaccines

Altimmune has expanded its previously-announced AdCOVID vaccine manufacturing collaboration with Lonza. Under the expanded agreement, Lonza will commission a dedicated …
News
Pharmafile's top 10 news roundup

Pharmafile.com’s top 10 news stories of the week

March 5, 2021 Medical Communications COVID, COVID-19, COVID-19 vaccine, news roundup, pharma news, roundup

The last week has seen its fair share of COVID-19 vaccine developments; Bharat Biotech’s candidate was found to be 81% …
News

FDA approves Roche’s Actemra/RoActemra treatment for rare lung disease

March 5, 2021 Medical Communications Actemra, RoActemra, Roche, SEC, systemic sclerosis

Roche’s Actemra/RoActemra therapy, intended for slowing the rate of decline in pulmonary function for adults with systemic sclerosis-associated interstitial lung …
News
amgen_flag

Amgen to acquire Five Prime Therapeutics for approximately $1.9bn

March 5, 2021 Medical Communications Amgen, Cancer, five prime

Amgen has announced it will acquire Five Prime Therapeutics for $38.00 per share in cash, representing an equity value of …
News

Novartis signs agreement to manufacture CureVac’s COVID-19 vaccine

March 5, 2021 Medical Communications COVID-19, CureVac, Novartis, vaccines

CureVac and Novartis have signed an initial agreement for the manufacturing of CureVac’s COVID-19 vaccine candidate, CVnCoV. Preparations for the …
News
houses_of_parliament_london_7654658782

UK government invests £5m in COVID-19 mRNA vaccine library

March 5, 2021 Medical Communications COVID-19, CPI, government, vaccines

The Centre for Process Innovation (CPI) has received a £5 million investment from the UK government, to support the development …
News

Verona Pharma appoints Novartis Gene Therapies VP Lisa Deschamps to its board

March 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, verona, verona pharma

Verona Pharma has appointed Lisa Deschamps, Senior Vice President and Chief Business Officer of Novartis Gene Therapies, as Non-Executive Director …
Appointment
sophie_biguenet_cmo_abivax

Abivax appoints Dr Sophie Biguenet as Chief Medical Officer

March 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical-stage biotechnology company Abivax has appointed Dr Sophie Biguenet as Chief Medical Officer. Dr Biguenet brings 25 years of experience …
Appointment
cov

MAPs during a global pandemic

February 26, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, MAPS

Early and managed access programmes provide opportunities for patients to get the treatments they need faster – but the COVID-19 …
Feature
top 10

Pharmafile.com’s top 10 news stories of the week

February 26, 2021 Medical Communications news, pharma news, pharmaceuticals, pharmafile, top news stories

COVID-19 news has slowed down in the last week, allowing different pharma developments to take centre stage. In the last …
News
GSK building

GSK’s Phase II otilimab study on COVID-19 patients promising for over-70s

February 26, 2021 Medical Communications COVID-19, GSK, coronavirus, covid-19 treatment, otilimab

GlaxoSmithKline’s (GSK) Phase II OSCAR study of their otilimab antibody’s effect on COVID-19 patients has shown promising results in older …
News

How COVID-19 has changed pharmacovigilance

February 26, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, pharmacovigilance

The race to provide vaccines and treatments for coronavirus has seen a number of COVID-19 drugs reach the market in …
Feature

NICE recommends Novartis’ ribociclib in combination with fulvestrant for breast cancer

February 26, 2021 Medical Communications Cancer, NICE, Novartis

NICE has recommended Novartis’ Kisqali (ribociclib) in combination with fulvestrant for women with prior endocrine therapy. It will be made …
News
merckincweb

MSD acquires Pandion Therapeutics in $1.85bn deal

February 26, 2021 Medical Communications MSD, Pandion

MSD, known as Merck in the United States and Canada, has announced that it will acquire clinical-stage biotechnology company Pandion …
News
The Gateway to Local Adoption Series

Latest content

Faron Pharmaceuticals appoints Heikki Jouttijärvi as Chief Technical Officer

April 2, 2026

Cambridge’s Grassroots Life Sciences Showcase Branches Out to Oxford & London

April 1, 2026

Doccla appoints Michael Macdonnell as Chief Strategy & Growth Officer and Deputy CEO

April 1, 2026

Bramacare launches new AI platform to improve eating disorder care

March 31, 2026

Doccla appoints Jonathan Serjeant as Chief Medical Officer

March 31, 2026